Dosing Sensitivity: Small differences in dose may influence tolerability, highlighting the need for careful monitoring
Most individuals find doses in the 50100 mg range welltolerated after rampup [5]
Most evidence remains preclinical, with limited controlled human research currently available
The combined effect: a bottle that should be good for 28 days can be unsafe at day 10 if multiple failure modes stack
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
However, if you experience any symptoms while on treatment with this medicine, let your doctor know